CDKN2B gene rs1063192 polymorphism decreases the risk of glaucoma

The aim of this meta-analysis was to evaluate the association between cyclin-dependent kinase Inhibitor-2B (CDKN2B) gene rs1063192 polymorphism and glaucoma risk. We searched the databases of PubMed, and Embase. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by using fix...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Zhenxian, He, Chenliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400574/
https://www.ncbi.nlm.nih.gov/pubmed/28416752
http://dx.doi.org/10.18632/oncotarget.15504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400574/
https://www.ncbi.nlm.nih.gov/pubmed/28416752
http://dx.doi.org/10.18632/oncotarget.15504

Ejemplares similares